Clonal hematopoiesis of indeterminate potential: recent developments and perspectives

Area of Science:

• Hematology
• Genetics
• Aging Research

Background:

• Clonal hematopoiesis of indeterminate potential (CHIP) is a common biological condition associated with aging.
• The incidence of CHIP increases with age, significantly influencing blood disease pathophysiology.
• Recent research expands CHIP's relevance to nonhematologic conditions like cardiovascular and liver diseases.

Purpose of the Study:

• To review recent findings on CHIP and its future prospects.
• To highlight advances in understanding CHIP risk factors and associated diseases.
• To provide insights for treating hematologic and nonhematologic disorders linked to CHIP.

Main Methods:

• Literature review of recently published information on CHIP.
• Analysis of studies investigating CHIP's association with aging and various diseases.
• Synthesis of current research on genetic testing and preventive medicine applications for CHIP.

Main Results:

• CHIP is a prevalent condition in aging populations, with incidence rising with age.
• CHIP significantly impacts the pathophysiology of both hematologic and nonhematologic diseases, including cardiovascular, renal, liver, and pulmonary conditions.
• Advancements in genetic testing and preventive medicine show CHIP as a promising target for disease prevention and management.

Conclusions:

• CHIP is associated with a diverse range of illnesses and significantly affects an individual's health prognosis.
• Early identification and effective management of CHIP are critical for improving clinical outcomes.
• Further research into CHIP holds promise for novel therapeutic strategies and disease prevention.